Literature DB >> 28571656

Development of a novel method for amniotic fluid stem cell storage.

Manuela Zavatti1, Francesca Beretti1, Francesca Casciaro1, Giuseppina Comitini2, Fabrizia Franchi3, Veronica Barbieri3, Laura Bertoni1, Anto De Pol1, Giovanni B La Sala4, Tullia Maraldi5.   

Abstract

BACKGROUND AIMS: Current procedures for collection of human amniotic fluid stem cells (hAFSCs) indicate that cells cultured in a flask for 2 weeks can then be used for research. However, hAFSCs can be retrieved directly from a small amount of amniotic fluid that can be obtained at the time of diagnostic amniocentesis. The aim of this study was to determine whether direct freezing of amniotic fluid cells is able to maintain or improve the potential of a sub-population of stem cells.
METHODS: We compared the potential of the hAFSCs regarding timing of freezing, cells obtained directly from amniotic fluid aspiration (D samples) and cells cultured in a flask before freezing (C samples). Colony-forming-unit ability, proliferation, morphology, stemness-related marker expression, senescence, apoptosis and differentiation potential of C and D samples were compared.
RESULTS: hAFSCs isolated from D samples expressed mesenchymal stem cells markers until later passages, had a good proliferation rate and exhibited differentiation capacity similar to hAFSCs of C samples. Interestingly, direct freezing induced a higher concentration of cells positive for pluripotency stem cell markers, without teratoma formation in vivo.
CONCLUSIONS: This study suggests that minimal processing may be adequate for the banking of amniotic fluid cells, avoiding in vitro passages before the storage and exposure to high oxygen concentration, which affect stem cell properties. This technique might be a cost-effective and reasonable approach to the process of Good Manufacturing Process accreditation for stem-cell banks.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amniotic fluid stem cells; direct freezing; stem-cell bank

Mesh:

Substances:

Year:  2017        PMID: 28571656     DOI: 10.1016/j.jcyt.2017.04.006

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  4 in total

1.  Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment.

Authors:  Kinji Furuya; Yun-Wen Zheng; Daisuke Sako; Kenichi Iwasaki; Dong-Xu Zheng; Jian-Yun Ge; Li-Ping Liu; Tomoaki Furuta; Kazunori Akimoto; Hiroya Yagi; Hiromi Hamada; Hiroko Isoda; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  World J Stem Cells       Date:  2019-09-26       Impact factor: 5.326

2.  Unravelling Heterogeneity of Amplified Human Amniotic Fluid Stem Cells Sub-Populations.

Authors:  Francesca Casciaro; Silvia Zia; Mattia Forcato; Manuela Zavatti; Francesca Beretti; Emma Bertucci; Andrea Zattoni; Pierluigi Reschiglian; Francesco Alviano; Laura Bonsi; Matilde Yung Follo; Marco Demaria; Barbara Roda; Tullia Maraldi
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

3.  Differentiation of CD117+ Amniotic Fluid Stem Cells towards Nephron Progenitors.

Authors:  Hina Jabeen; Mohsin Wahid; Jahan Ara Ain Uddin; Farrukh Mustafa
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

4.  Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging.

Authors:  Francesca Casciaro; Francesca Beretti; Manuela Zavatti; James A McCubrey; Stefano Ratti; Sandra Marmiroli; Matilde Y Follo; Tullia Maraldi
Journal:  Aging (Albany NY)       Date:  2018-10-24       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.